FDA Issues Another Form 483 to Biocon Over Bangalore Facility – The Center for Biosimilars



FDA Issues Another Form 483 to Biocon Over Bangalore Facility  The Center for Biosimilars

The FDA has issued a new Form 483 to Biocon over the Bangalore facility where it produces its biosimilars. The document makes 2 inspection observations that …



Read the full Bangalore News here

Some local news is curated - Original might have been posted at a different date/ time! Click the source link for details.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.